首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Hesperidin induces apoptosis and triggers autophagic markers through inhibition of Aurora-A mediated phosphoinositide-3-kinase/Akt/mammalian target of rapamycin and glycogen synthase kinase-3 beta signalling cascades in experimental colon carcinogenesis
【24h】

Hesperidin induces apoptosis and triggers autophagic markers through inhibition of Aurora-A mediated phosphoinositide-3-kinase/Akt/mammalian target of rapamycin and glycogen synthase kinase-3 beta signalling cascades in experimental colon carcinogenesis

机译:橙皮苷通过抑制Aurora-A介导的雷帕霉素磷酸肌醇-3-激酶/ Akt /哺乳动物靶标和糖原合酶激酶-3β信号级联在实验性结肠癌的发生中诱导凋亡并触发自噬标记

获取原文
获取原文并翻译 | 示例
           

摘要

Abnormalities in the homeostasis mechanisms involved in cell survival and apoptosis are contributing factors for colon carcinogenesis. Interventions of these mechanisms by pharmacologically safer agents gain predominance in colon cancer prevention. We previously reported the chemopreventive efficacy of hesperidin against colon carcinogenesis. In the present study, we aimed at investigating the potential of hesperidin over the abrogated Aurora-A coupled pro-survival phosphoinositide-3-kinase (PI3K)/Akt signalling cascades. Further, the role of hesperidin over apoptosis and mammalian target of rapamycin (mTOR) mediated autophagic responses were studied. Azoxymethane (AOM) induced mouse model of colon carcinogenesis was involved in this study. Hesperidin treatment was provided either in initiation/post-initiation mode respectively. Hesperidin significantly altered AOM mediated anti-apoptotic scenario by modulating Bax/Bcl-2 ratio together with enhanced cytochrome-c release and caspase-3, 9 activations. In addition, hesperidin enhanced p53-p2.1 axis with concomitant decrease in cell cycle regulator. Hesperidin treatment caused significant up-regulation of tumour suppressor phosphatase and tensin homologue (PTEN) with a reduction in the expression of AOM mediated p-PI3K and p-Akt. Additionally, hesperidin administration exhibited inhibition against p-mTOR expression which in turn led to stimulation of autophagic markers Beclin-1 and LC3-II. Aurora-A an upstream regulator of PI3K/Akt pathway was significantly inhibited by hesperidin. Furthermore, hesperidin administration restored gly-cogen synthase kinase-3 beta (GSK-3beta) activity which in turn prevented the accumulation of oncoproteins beta-catenin, c-jun and c-myc. Taken together, hesperidin supplementation initiated apoptosis via targeted inhibition of constitutively activated Aurora-A mediated PI3K/ Akt/GSK-3beta and mTOR pathways coupled with autophagic stimulation against AOM induced colon carcinogenesis.
机译:参与细胞存活和凋亡的体内稳态机制异常是结肠癌发生的因素。通过药理学上更安全的药物对这些机制的干预在结肠癌的预防中占主导地位。我们以前曾报道过橙皮苷对结肠癌的化学预防作用。在本研究中,我们旨在研究橙皮苷对废除的Aurora-A偶联的生存前磷酸肌醇3激酶(PI3K)/ Akt信号级联反应的潜力。此外,还研究了橙皮苷在细胞凋亡和雷帕霉素(mTOR)介导的自噬反应的哺乳动物靶标中的作用。这项研究涉及了由甲氧基甲烷(AOM)诱导的结肠癌小鼠模型。橙皮苷治疗分别以启动/启动后模式提供。橙皮苷可通过调节Bax / Bcl-2比例以及增强的细胞色素C释放和caspase-3 9活化来显着改变AOM介导的抗凋亡情况。此外,橙皮苷增强了p53-p2.1轴,伴随着细胞周期调节剂的减少。橙皮苷治疗显着上调了肿瘤抑制酶磷酸酶和张力蛋白同源物(PTEN),并降低了AOM介导的p-PI3K和p-Akt的表达。另外,橙皮苷给药显示出对p-mTOR表达的抑制,这反过来又导致自噬标记物Beclin-1和LC3-II的刺激。橙皮苷显着抑制了PI3K / Akt途径的上游调节剂Aurora-A。此外,橙皮苷的给药恢复了糖原合酶激酶3 beta(GSK-3beta)的活性,从而阻止了癌蛋白β-catenin,c-jun和c-myc的积累。综上所述,橙皮苷补充剂通过靶向抑制组成性激活的Aurora-A介导的PI3K / Akt / GSK-3beta和mTOR通路,以及针对AOM诱导结肠癌发生的自噬刺激,来启动细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号